Body Weight: Clinical Trials

15,190 trials for Body Weight, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9468 completed, 1898 unknown, 1493 recruiting, 656 active not recruiting. 8946 Not applicable, 1071 Phase 2, 849 Phase 1, 759 Phase 3, 659 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8946Completed 5804, Unknown 1114, Recruiting 788, Active not recruiting 371, Not yet recruiting 327, Terminated 276, Withdrawn 187, Enrolling by invitation 67, Suspended 12
Phase 21071Completed 669, Recruiting 113, Unknown 73, Terminated 68, Active not recruiting 60, Not yet recruiting 45, Withdrawn 36, Enrolling by invitation 4, Suspended 3
Phase 1849Completed 551, Recruiting 118, Active not recruiting 46, Not yet recruiting 40, Unknown 39, Terminated 36, Withdrawn 17, Enrolling by invitation 1, Suspended 1
Phase 3759Completed 434, Recruiting 96, Unknown 67, Terminated 51, Active not recruiting 49, Not yet recruiting 43, Withdrawn 15, Suspended 4
Phase 4659Completed 383, Unknown 96, Recruiting 50, Not yet recruiting 42, Terminated 36, Active not recruiting 25, Withdrawn 22, Enrolling by invitation 4, Suspended 1
Early Phase 1133Completed 68, Unknown 19, Recruiting 15, Withdrawn 10, Active not recruiting 7, Not yet recruiting 5, Terminated 5, Suspended 3, Enrolling by invitation 1

Follow Body Weight: new trials by email Literature Review of Body Weight trials Research Report on Body Weight

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Machine Learning and 3D Image-Based Modeling for Real-Time Body Weight and Body Composition Estimation During Emergency Medical Care. Study 3
Weight estimation using 3D camera - Body Weights and Measures, Body Weight in the Overweight and Obese Class - I Population
Not applicableWithdrawnFlorida Atlantic University2029-07-012025-12-19
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
Polylactose, Placebo - Obesity, Adolescent, Obesity, Childhood
Not applicableWithdrawnUniversity of Minnesota2028-05-012025-07-11
A Study of Body Fat Distribution and Airway Mechanics in Healthy Adults
Body positioning - Healthy Volunteers Only
Not applicableNot yet recruitingMaurizio F. Cereda, MD202028-01-012025-06-18
Adiposity Distribution in Acute Respiratory Failure
PEEP Titration Using Electrical Impedance Tomography (EIT), Body Positioning: Supine and Prone - Acute Hypoxemic Respiratory Failure, Obesity
Not applicableNot yet recruitingMaurizio F. Cereda, MD802028-01-012025-06-13
Community Active and Healthy Families Pragmatic Trial
Community Active and Healthy Families Intensive Health Behavior and Lifestyle Treatment - Child Obesity
Phase 4Not yet recruitingUniversity of Colorado, Denver4162028-01-012026-10-09
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
AI-informed behavioral intervention, Standard behavioral intervention, Health Education - Obesity (Disorder)
Not applicableNot yet recruitingAikaterini Karaivazoglou8402027-09-012026-04-14
Machine Learning and 3D Image-Based Modeling for Real-Time Body Weight and Body Composition Estimation During Emergency Medical Care: Study 2
3D camera weight estimate, Standard methods of weight estimation - Body Weights and Measures, Body Weight in the Overweight and Obese Class - I Population
WithdrawnFlorida Atlantic University2027-07-012025-12-19
Modifying Diet to Improve Gut Microbiome
DASH diet, standard American diet - Obesity
Not applicableNot yet recruitingH. Lee Moffitt Cancer Center and Research Institute282027-07-012026-09-17
Learning Early Infant Feeding Cues
Learning Early Infant Feeding Cues - Responsive Feeding, Infants
Not applicableNot yet recruitingFlorida State University392027-07-012026-04-27
Simplifying Diet Tracking in a Digital Weight Loss Intervention
Simplified Dietary Self-Monitoring, Detailed Dietary Self-Monitoring, Core Behavioral Weight Loss Intervention - Overweight, Obesity
Not applicableNot yet recruitingStanford University3282027-05-012026-05-28
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
ESG with OverStitch - Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Not applicableNot yet recruitingBoston Scientific Corporation502027-04-012026-10-23
Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
NutriAct plus, Rescue VLCD - Obesity & Overweight, Weight Loss Maintenance
Not applicableNot yet recruitingKnut Mai2922027-03-012026-07-20
Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
Pecan, Control - Nutrition, Healthy, Dyslipidemia
Not applicableNot yet recruitingUniversity of Georgia902027-03-012026-08-11
Optimization of Dietary Adherence in a Mobile Weight Loss Intervention
Core, Switch to Simplified Diet Monitoring, Goal Autonomy/Planning - Overweight and/or Obesity
Not applicableNot yet recruitingUNC Lineberger Comprehensive Cancer Center5802027-03-012026-05-15
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
LUM-201, Placebo, Semagludtide - Obesity & Overweight
Phase 2Not yet recruitingLumos Pharma2022027-02-152026-08-10
BRE-13: Mediterranean Diet
Explore the effect of MedDiet vs. Usual Diet on Fatty Acid Profile, Explore the effect of MedDiet vs. Usual Diet on Breast Tumor Tissue, Explore the effect of MedDiet vs. Usual Diet on Lipids - Dietary Assessment, Dietary and Lifestyle Behaviour Change
Not applicableNot yet recruitingUniversity of Illinois at Chicago302027-02-152026-10-09
Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients
Tirzepatide - Obesity / Overweight
Not yet recruitingNanjing First Hospital, Nanjing Medical University802027-02-012026-10-15
Semaglutide for Low Back Pain
Semaglutide (administered by PDS290 pen-injector), Placebo (administered by PDS290 pen-injector) - Lower Back Pain, Obesity (BMI>30)
Phase 2Not yet recruitingWashington University School of Medicine2502027-02-012026-07-28
EMBodied psychOsocial Impacts of Weight Stigma During Pregnancy (EMBODY): A Prospective Cohort Study
Weight Stigma, Pregnancy Outcomes
Not yet recruitingMonash University8002027-02-012026-10-16
OLE Study Subsequent to Parent Study of Rilogrotug for the Treatment of Weight Loss and Anorexia in Patients With Cancer Cachexia and mCRC or mNSCLC
Rilogrotug - Cachexia; Cancer, Cachexia
Phase 2 / Phase 3Not yet recruitingAVEO Pharmaceuticals, Inc.4002027-02-012026-10-22

Showing 20 of 15190. Sign in to see all of them.

Narrower conditions

Obesity (11336)  ·  Overweight (3525)  ·  Weight Loss (1793)  ·  Motor Activity (1291)  ·  Diabetes Mellitus, Type 2 (1168)  ·  Pediatric Obesity (1121)  ·  Obesity, Morbid (931)  ·  Diabetes Mellitus (876)  ·  Insulin Resistance (828)  ·  Metabolic Syndrome (767)  ·  Hypertension (602)  ·  Cardiovascular Diseases (496)  ·  Inflammation (349)  ·  Feeding Behavior (311)

Broader conditions

Pathological Conditions, Signs and Symptoms (15185)  ·  Signs and Symptoms (15175)  ·  Nutritional and Metabolic Diseases (13859)  ·  Nutrition Disorders (13513)  ·  Overnutrition (13447)  ·  Overweight (9963)  ·  Metabolic Diseases (3542)  ·  Glucose Metabolism Disorders (3296)  ·  Endocrine System Diseases (2465)  ·  Body Weight Changes (2415)  ·  Behavior (2395)  ·  Obesity (1670)  ·  Hyperinsulinism (1435)  ·  Diabetes Mellitus (1358)

Interventions

Exercise (546)  ·  Diet (264)  ·  semaglutide (229)  ·  Bariatric Surgery (169)  ·  Tirzepatide (150)  ·  Metformin (147)  ·  Liraglutide (132)  ·  Caloric Restriction (125)  ·  Gastric Bypass (120)  ·  Nutrition Assessment (114)  ·  Control Groups (104)  ·  Resistance Training (96)  ·  Diet Therapy (93)  ·  Standard of Care (90)  ·  Sodium Chloride (75)

Sponsors

Novo Nordisk A/S (202)  ·  University of Colorado, Denver (126)  ·  Mayo Clinic (122)  ·  Eli Lilly and Company (118)  ·  Pennington Biomedical Research Center (111)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (107)  ·  Washington University School of Medicine (103)  ·  The Miriam Hospital (96)  ·  Maastricht University Medical Center (93)  ·  Massachusetts General Hospital (92)  ·  University of Alabama at Birmingham (92)  ·  University of Copenhagen (92)  ·  University of North Carolina, Chapel Hill (92)  ·  Yale University (92)  ·  University of Pittsburgh (91)

Countries

United States (6157)  ·  Canada (712)  ·  China (711)  ·  France (601)  ·  United Kingdom (553)  ·  Spain (505)  ·  Turkey (Türkiye) (477)  ·  Italy (446)  ·  Denmark (436)  ·  Germany (420)  ·  Brazil (347)  ·  Netherlands (311)  ·  Mexico (250)  ·  Sweden (246)  ·  Egypt (241)

Top investigators

Samuel Klein, MD (24)  ·  Jack A Yanovski, M.D. (20)

Results publications

PMID 38375882, PMID 33512717, PMID 26708836, PMID 29718281, PMID 30230252, PMID 33238176, PMID 38376518, PMID 40839263, PMID 41029405, PMID 24500151, PMID 26210388, PMID 30122305, PMID 38271099, PMID 28386912, PMID 28950422, PMID 30651576, PMID 33782940, PMID 34611902, PMID 42014131, PMID 15479938, PMID 22085317, PMID 23987123, PMID 24570244, PMID 26599819, PMID 27482610, PMID 27817208, PMID 28473337, PMID 31004409, PMID 32002540, PMID 32909523, PMID 33567185, PMID 37652841, PMID 38698650, PMID 39226070, PMID 39952695, PMID 40705619, PMID 11832527, PMID 17715408, PMID 18392907, PMID 18673303, PMID 19858703, PMID 20573639, PMID 20798995, PMID 21932999, PMID 22449319, PMID 22963820, PMID 23661689, PMID 23703580, PMID 24586896, PMID 25343235

NIH funding

2025 (55), 2023 (39), 2017 (27), 2019 (22), 2018 (19), 2015 (16), 2014 (15), 2016 (14), 2009 (13), 2008 (11), UL1TR001082 (10), P50MD017338 (9), R01DK059853 (6), UL1TR000135 (6), 2005 (5)